A multi-criteria decision making approach to identify a vaccine formulation.

about

Potential Antitumor Activity and Apoptosis Induction of Glossostemon bruguieri Root Extract against Hepatocellular Carcinoma Cells.

P2860

Q38831293-81910A7B-5E9D-4FF9-926B-7C38219D9B0D

P2860

A multi-criteria decision making approach to identify a vaccine formulation.

Item

http://www.wikidata.org/entity/Q41534119

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A multi-criteria decision making approach to identify a vaccine formulation.

@en

type

Item

label

A multi-criteria decision making approach to identify a vaccine formulation.

@en

prefLabel

A multi-criteria decision making approach to identify a vaccine formulation.

@en

P1476

A multi-criteria decision making approach to identify a vaccine formulation.

@en

P2093

Christelle Durand

http://www.w3.org/2001/XMLSchema#string

Jeanne-Marie Devaster

http://www.w3.org/2001/XMLSchema#string

Lidia Oostvogels

http://www.w3.org/2001/XMLSchema#string

Marc Fourneau

http://www.w3.org/2001/XMLSchema#string

Sandie Marion

http://www.w3.org/2001/XMLSchema#string

Walthère Dewé

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults

Statistical evaluation of HIV vaccines in early clinical trials.

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.

A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

Effectiveness of influenza vaccine in the community-dwelling elderly.

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial.

P304

352-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10543406.2015.1008517

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25616785

http://www.w3.org/2001/XMLSchema#string

A multi-criteria decision making approach to identify a vaccine formulation.

about

P2860

P2860

A multi-criteria decision making approach to identify a vaccine formulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698